Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme

被引：9
|
作者：
Schiff, David [1 ]
Purow, Benjamin [2 ]
机构：
[1] Univ Virginia, Neurooncol Ctr, Charlottesville, VA 22908 USA
[2] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2008年 / 5卷 / 04期
关键词：
bevacizumab; glioblastoma multiforme; irinotecan; survival; toxicity;
D O I：
10.1038/ncponc1077
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：186 / 187
页数：2
相关论文
共 50 条
  • [1] Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme
    David Schiff
    Benjamin Purow
    [J]. Nature Clinical Practice Oncology, 2008, 5 : 186 - 187
  • [2] Irinotecan and bevacizumab in recurrent glioblastoma multiforme
    Jakobsen, Jan Nyrop
    Hasselbalch, Benedikte
    Stockhausen, Marie-Therese
    Lassen, Ulrik
    Poulsen, Hans Skovgaard
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (05) : 825 - 833
  • [3] Bevacizumab and irinotecan in patients with recurrent glioblastoma multiforme (GBM)
    Raval, Sumul N.
    Rule, Amy
    Hwang, Shirley S.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 482 - 482
  • [4] Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
    Vredenburgh, James J.
    Desjardins, Annick
    Herndon, James E., II
    Marcello, Jennifer
    Reardon, David A.
    Quinn, Jennifer A.
    Rich, Jeremy N.
    Sathornsumetee, Sith
    Gururangan, Sridharan
    Sampson, John
    Wagner, Melissa
    Bailey, Leighann
    Bigner, Darell D.
    Friedman, Allan H.
    Friedman, Henry S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) : 4722 - 4729
  • [5] Bevacizumab and irinotecan in patients (pts) with recurrent glioblastoma multiforme (GBM)
    Raval, S.
    Hwang, S.
    Dorsett, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] A meta-analysis of bevacizumab alone and in combination with irinotecan in the treatment of patients with recurrent glioblastoma multiforme
    Zhang, Guobin
    Huang, Shengyue
    Wang, Zhongcheng
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (12) : 1636 - 1640
  • [7] Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
    Friedman, Henry S.
    Prados, Michael D.
    Wen, Patrick Y.
    Mikkelsen, Tom
    Schiff, David
    Abrey, Lauren E.
    Yung, W. K. Alfred
    Paleologos, Nina
    Nicholas, Martin K.
    Jensen, Randy
    Vredenburgh, James
    Huang, Jane
    Zheng, Maoxia
    Cloughesy, Timothy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : 4733 - 4740
  • [8] Radiographic evaluation of recurrent glioblastoma multiforme (gbm) in patients treated with bevacizumab and irinotecan
    Andre, Jalal
    Spearman, Kenneth
    Lu, Stanley
    Raval, Sumul
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 575 - 575
  • [9] Radiographic evaluation of recurrent glioblastoma multiforme (GBM) in patients treated with bevacizumab and irinotecan
    Andre, J.
    Spearman, K.
    Lu, S.
    Hwang, S.
    Dorsett, L.
    Raval, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Reinduction of Bevacizumab in Combination with Pegylated Liposomal Doxorubicin in a Patient with Recurrent Glioblastoma Multiforme Who Progressed on Bevacizumab/Irinotecan
    Almubarak, Mohammed
    Newton, Michael
    Altaha, Ramin
    [J]. JOURNAL OF ONCOLOGY, 2008, 2008
12345